I understand but that wasn't the gist of my post. And wasn't it originally suppose to start at the end of 2015 to begin with?

Actually, company originally stated P2 trials to commence in 3rd quarter of 2015

http://www.amarantus.com/news/press-releases/...versity-in

Quote:

---

Amarantus is developing ESS for the treatment of severe burns and is preparing to commence Phase 2 clinical studies in the third quarter of 2015.

---

As I stated, delays are understandable in biotech but a pattern of false claims is not.